Drug Detail:Jardiance (Empagliflozin [ em-pa-gli-floe-zin ])
Generic Name: empagliflozin 10mg
Dosage Form: tablet, film coated
Drug Class: SGLT-2 inhibitors
Prior to Initiation of JARDIANCE
- •
- Assess renal function before initiating JARDIANCE and as clinically indicated [see Warnings and Precautions (5.2) ] .
- •
- In patients with volume depletion, correct this condition before initiating JARDIANCE [see Warnings and Precautions (5.2), Use in Specific Populations (8.5, 8.6)].
Recommended Dosage
- •
- The recommended dose of JARDIANCE is 10 mg once daily in the morning, taken with or without food.
- •
- For additional glycemic control, the dose may be increased to 25 mg in patients tolerating JARDIANCE.
- •
- Use for glycemic control is not recommended in patients with an eGFR less than 30 mL/min/1.73 m 2 .
- •
- Data are insufficient to provide a dosing recommendation in patients;
- •
- who have type 2 diabetes and established cardiovascular disease with an eGFR less than 30 mL/min/1.73 m2, or
- •
- who have heart failure with an eGFR less than 20 mL/min/1.73 m2 [see Warnings and Precautions (5.2) and Use in Specific Populations (8.6)].
- •
- JARDIANCE is contraindicated in patients on dialysis [see Contraindications (4) ] .